AMBI vs AKTX

Comparison between Ambipar Emergency Response - Class A (AMBI, Company) and Akari Therapeutics Plc (AKTX, Company).

AMBI is from the Industrials sector, while AKTX is from the Healthcare sector.

AMBI vs AKTX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	AMBI(COMPANY)	AKTX(COMPANY)
Market Cap	$148M	$148M
Max Drawdown	96.93%	99.99%
Sharpe Ratio	-1.23	0.26
5Y Beta	N/A	0.61
Industry	Waste Management	Biotechnology
P/E Ratio	-103.26	-8.66
PEG Ratio	N/A	0.00
Debt to Equity	N/A	0.00%
Free Cash Flow Yield	N/A	-6.52%
P/S Ratio	0.27	478368.50
P/B Ratio	0.81	1.14

Market Cap

AMBI

$148M

Winner

AKTX

$148M

Max Drawdown

Winner

AMBI

96.93%

AKTX

99.99%

Sharpe Ratio

AMBI

-1.23

Winner

AKTX

0.26

5Y Beta

AMBI

N/A

AKTX

0.61

Industry

AMBI

Waste Management

AKTX

Biotechnology

P/E Ratio

Winner

AMBI

-103.26

AKTX

-8.66

PEG Ratio

AMBI

N/A

AKTX

0.00

Debt to Equity

AMBI

N/A

AKTX

0.00%

Free Cash Flow Yield

AMBI

N/A

AKTX

-6.52%

P/S Ratio

Winner

AMBI

0.27

AKTX

478368.50

P/B Ratio

Winner

AMBI

0.81

AKTX

1.14

AMBI vs AKTX - Historical Returns

Returns include dividend reinvestment.

Period	AMBI	AKTX
1 month	+0.00%	+212.57%
3 months	+0.00%	+68.20%
6 months	N/A	+11.63%
1 year	-88.64%	-76.22%
5 years(CAGR)	N/A	-62.20%
10 years(CAGR)	N/A	-50.21%
Max(CAGR)	-65.27%	-51.37%

AMBI

+0.00%

Winner

AKTX

+212.57%

AMBI

+0.00%

Winner

AKTX

+68.20%

AMBI

N/A

AKTX

+11.63%

AMBI

-88.64%

Winner

AKTX

-76.22%

5Y(CAGR)

AMBI

N/A

AKTX

-62.20%

10Y(CAGR)

AMBI

N/A

AKTX

-50.21%

Max(CAGR)

AMBI

-65.27%

Winner

AKTX

-51.37%

AMBI vs AKTX - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	AMBI	AKTX
2026	+0.00%	-5.69%
2025	-89.91%	-76.12%
2024	-30.21%	-57.88%
2023	-55.38%	-68.39%
2022	N/A	-68.88%
2021	N/A	-17.13%
2020	N/A	+6.32%
2019	N/A	+5.11%
2018	N/A	-64.24%
2017	N/A	-42.27%
2016	N/A	-48.42%
2015	N/A	-53.97%